Cell And Gene Therapy Videos

  1. Aldevron Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    In this session, you will discover how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA research and development pipeline.

  2. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  3. Beyond CRISPR: Next-Gen Gene Editing With TARGATT, Mad7, Base Editing 1/17/2025

    Consider several gene editing technologies — TARGATT, Mad7, and Base Editing — and gain insights into their transformative applications in genetic engineering and therapeutic development.

  4. The Future Of Allogeneic Cell Therapy: Hypoimmunogenic Donor Cells 1/17/2025

    Explore how TARGATT® gene editing and HLA-F technologies are revolutionizing hypoimmunogenic cell development for scalable allogeneic therapies.

  5. The Crucial Role Of Apheresis In Cellular Therapies 1/8/2025

    Gain valuable insights into the critical role of apheresis in sourcing high-quality cellular material for therapies.

  6. BioPhorum Raw Materials Risk Assessments 12/19/2024

    Torsten Schaderdorf provides an in-depth exploration of current regulations related to Raw Materials Risk Assessment, highlighting the risk criteria and raw material scope outlined in the BioPhorum guidelines.

  7. How Standardized Extractables Data Support E&L Risk Assessment 12/19/2024

    Explore E&L evaluations, USP <665>, supplier-provided extractables data, and collaborative strategies to mitigate risks in Single-Use Systems for biopharmaceutical manufacturing processes.

  8. Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics 12/12/2024

    Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.

  9. Leveraging Platform Processes For Developing And Accelerating Novel Gene And Cancer Therapeutics 12/5/2024

    Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.

  10. Early Preclinical Development: A Successful Transition To cGMP Manufacturing 12/2/2024

    Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.